EPS for Walgreens Boots Alliance, Inc. (WBA) Expected At $1.44

September 22, 2018 - By Alicia Butler

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Logo

Analysts expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to report $1.44 EPS on October, 24.They anticipate $0.13 EPS change or 9.92 % from last quarter’s $1.31 EPS. WBA’s profit would be $1.43 billion giving it 12.67 P/E if the $1.44 EPS is correct. After having $1.53 EPS previously, Walgreens Boots Alliance, Inc.’s analysts see -5.88 % EPS growth. The stock increased 0.15% or $0.11 during the last trading session, reaching $73. About 5.90M shares traded. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has declined 14.94% since September 23, 2017 and is downtrending. It has underperformed by 30.56% the S&P500.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Coverage

Among 13 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 3 have Buy rating, 1 Sell and 9 Hold. Therefore 23% are positive. Walgreens Boots Alliance had 14 analyst reports since March 28, 2018 according to SRatingsIntel. Scotia Capital maintained Walgreens Boots Alliance, Inc. (NASDAQ:WBA) rating on Monday, April 2. Scotia Capital has “Buy” rating and $9100 target. The rating was downgraded by Jefferies to “Hold” on Friday, June 29. Leerink Swann maintained the stock with “Market Perform” rating in Wednesday, May 23 report. The stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has “Buy” rating given on Wednesday, March 28 by Guggenheim. The stock has “Neutral” rating by Citigroup on Monday, July 9. As per Wednesday, June 27, the company rating was maintained by Pivotal Research. The stock has “In-Line” rating by Evercore on Tuesday, July 10. The firm has “Buy” rating by RBC Capital Markets given on Wednesday, March 28. Cowen & Co downgraded Walgreens Boots Alliance, Inc. (NASDAQ:WBA) on Monday, July 23 to “Market Perform” rating. The stock has “Underweight” rating by Bank of America on Thursday, June 28.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The company has market cap of $72.45 billion. It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. It has a 17.18 P/E ratio. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

More important recent Walgreens Boots Alliance, Inc. (NASDAQ:WBA) news were published by: 247Wallst.com which released: “Intel, Walgreens Push the Dow Higher Thursday” on September 20, 2018, also Seekingalpha.com published article titled: “Fred’s Inc: A Discounted Retailer”, Nasdaq.com published: “6 Monthly Dividend Stocks to Buy” on September 14, 2018. More interesting news about Walgreens Boots Alliance, Inc. (NASDAQ:WBA) was released by: Seekingalpha.com and their article: “All eyes on Amazon store plan” with publication date: September 20, 2018.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.